Inspection Record

American Red Cross Blood Services — FDA 483 Findings

US FDAInspected 2015-07-11Published 2024-01-17 5 findingsMaterial and supplier controlOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Material and supplier control

Failure (b)(4) to notify FDA's Baltimore District Office and/or CBER within 45 days after learning that a unit of unsuitable blood or blood component was distributed.

2Other quality system

The firm's entitled that they must develop a problems and within 45 meet these time frames for the follOWing problems: a.

3Other quality system

Written standard operating procedures were not followed.

4Other quality system

The firm failed to promptly, thoroughly and adequately investigate l correct and take steps to prevent the recurrence of each problem.

5Material and supplier control

The firm failed to notify ~onsignee and/or FDA's Baltimore District Office within 48 hours after learning that a unit of unsuitable blood or blood component has been distributed.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

American Red Cross Blood Services company profile — full history US FDA documents, 2024 Go to Findings search